Motusmedica, MB - financials and debts

Company age: 4 y. 9 mo.

Update

Motusmedica - Company finances

EUR
2021
From: 2021-12-14
To: 2021-12-31
2022
From: 2022-01-01
To: 2022-12-31
2023
From: 2023-01-01
To: 2023-12-31
2024
From: 2024-01-01
To: 2024-12-31
2025
From: 2025-01-01
To: 2025-12-31
Financial data
Sales revenue 180 1,515 36,242 33,015 65,078
Profit before tax 180 -3,444 24,056 2,072 4,266
Net profit 180 -3,444 23,036 1,968 4,010
Equity 1,180 366 20,557 22,525 26,535
Liabilities - 59 1,387 1,116 20,506
Non-current assets 0 0 0 9,291 34,384
Current assets 2,180 425 21,944 14,350 12,657
Total assets 2,180 425 21,944 23,641 47,041
Taxes paid
STI taxes - - - 965 294
Financial indicators
Revenue change y/y - +741.7% +2292.2% -8.9% +97.1%
ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. 8.3% -810.4% 105.0% 8.3% 8.5%
ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. 15.3% -941.0% 112.1% 8.7% 15.1%
Profit margin Net profit margin. Shows the overall profitability of the company. 100.0% -227.3% 63.6% 6.0% 6.2%
EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. 100.0% -227.3% 66.4% 6.3% 6.6%
Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. - 0.2 0.1 0.0 0.8
Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. - - - - 65,078

Purchase full financial statements

Profit/Loss, Balance Sheet, Cash Flow, Equity

9.99 € + PVM Buy

See Scoris data in Google Search

Mark Scoris as a favorite source. One click, no registration.

Motusmedica - Social security debts

From To Debt, €
2026-02-18 2026-02-22 0.04

Motusmedica - VMI tax arrears

From To Overdue, €
2025-06-27 2025-06-30 0.3
2025-06-26 2025-06-26 104.0

VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.

Analysis of the company's financial position

This description was generated by artificial intelligence. Report if inaccurate.
Motusmedica, MB (company code 305954424) is a Lithuanian small partnership operating in other human health activities n.e.c. In the latest financial year, 2025, the company generated revenue of €65.1K and net profit of €4.0K, with a profit margin of 6.2%. Revenue increased sharply year on year by 97.1% and was also 79.6% higher than two years earlier, indicating a strong recovery after the weaker 2024 result. Profitability followed a similar pattern: net profit fell from €23.0K in 2023 to €2.0K in 2024, then improved to €4.0K in 2025, although it remained below the 2023 level. At the end of 2025, total assets stood at €47.0K, supported by equity of €26.5K and liabilities of €20.5K. The equity ratio was 56.4% and debt-to-equity 0.77, showing a moderately leveraged balance sheet. Asset turnover was 1.38x, while return on equity reached 15.1% and return on assets 8.5%. Revenue per employee was €65.1K and profit per employee €4.0K.